Business ❯ Pharmaceutical Industry ❯ Drug Development

FDA Approval

Market Impact Drug Safety Aduhelm Omalizumab (Xolair) Approval Legal Challenges Clinical Trials

FDA Approves J&J’s Inlexzo Bladder Drug-Delivery Device for BCG‑Unresponsive NMIBC

The gemcitabine-releasing system offers a bladder-sparing option for adults with carcinoma in situ who are ineligible for or decline cystectomy.